Active substance
Iron
- Health Canada 7
- Safety 2
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACCRUFER | 02550679 | 30 MG | CAPSULE · ORAL | KYE PHARMACEUTICALS INC. |
| FERINJECT | 02546078 | 50 MG / ML | DISPERSION · INTRAVENOUS | VIFOR (INTERNATIONAL) INC. |
| FERRLECIT | 02243333 | 12.5 MG / ML | SOLUTION · INTRAVENOUS | SANOFI-AVENTIS CANADA INC |
| MONOFERRIC | 02477777 | 100 MG / ML | SOLUTION · INTRAVENOUS | PHARMACOSMOS A/S |
| PMS-IRON SUCROSE | 02502917 | 20 MG / ML | SOLUTION · INTRAVENOUS | PHARMASCIENCE INC |
| VELPHORO | 02471574 | 500 MG | TABLET (CHEWABLE) · ORAL | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD |
| VENOFER | 02243716 | 20 MG / ML | SOLUTION · INTRAVENOUS | AMERICAN REGENT, INC |
Safety signals and safety-related labeling changes
- EMA PRAC 31 Oct 2019 PRAC signal: Arteriospasm coronary
Action for MAH: update of the product information: Yes - EMA PRAC 16 May 2019 PRAC signal: Arteriospasm coronary
Action for MAH: update of the product information: No
Combinations containing Iron
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.